Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Linnaeus Bioscience

Linnaeus Bioscience
2012 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of a bacterial cytological profiling platform intended to accelerate the discovery efforts of the pharmaceutical industry. The company's bacterial cytological profiling platform determines the mode of action for newly discovered antimicrobial compounds, screens chemical and natural product libraries and provide high resolution images of bacterial pathogens treated with antimicrobials, enabling clients to develop specific projects or assays to meet their demanding needs and to contribute to the global fight against antibiotic resistant bacteria.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Social/Platform Software
Other Pharmaceuticals and Biotechnology
Primary Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Linnaeus Bioscience’s full profile, request a free trial.

Linnaeus Bioscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 02-Oct-2012 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Linnaeus Bioscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0

Linnaeus Bioscience Executive Team (2)

Name Title Board
Seat
Contact
Info
Joe Pogliano Ph.D Co-Founder & Chief Executive Officer
Kit Pogliano Co-Founder